27 jun: Carlsberg/RBC: Indleder dækning med "sector perform"
28 jun: USA/aktier: Opløstende nøgletal løftede markedet
27-06-2012 23:56:00

WSJ BLOG/Health: Pharmacies Try Offering Free HIV Testing

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Timothy W. Martin

Pharmacists and other drugstore staff already conduct tests for high-blood pressure, cholesterol levels and diabetes at in-store clinics.

Now, in a pilot program with federal health officials announced Tuesday, Walgreen Co. and other pharmacies will examine whether they can become a go-to stop for those seeking HIV testing.

So far, seven stores -- including three operated by Walgreen in Chicago, Washington D.C. and Lithonia, Ga. -- are offering the HIV tests for free. Spotting a patient early on with HIV decreases the likelihood the disease will be transmitted to other people and helps get an infected individual on drug treatment and therapy earlier.

By the end of the summer, the Centers for Disease Control and Prevention plans to add 17 more pharmacies to the pilot program, dividing the participating drug stores equally between urban and rural locations.

The CDC estimates 1.1 million people in the U.S. live with HIV, but nearly one in five of those infected is unaware of their condition. Health officials six years ago recommended that all adolescents and adults between the ages of 13 to 64 get tested at least once for HIV.

Testing numbers have risen in recent years. About 45% of Americans aged 18 to 64 in 2009 had reported getting tested for HIV at some point in their lives, according to CDC research, up from the 40% observed in 2006.

The two-year pilot is a test run for how drug stores and community pharmacies across the country could one day offer HIV testing. CDC officials will study the amount of time, resources and cost required.

"We want to get a sense of how cumbersome this process would be and the approximate cost of the service for the pharmacies," Kevin Fenton, a CDC director for the center focusing on HIV/AIDS, tells the Health Blog.

The findings will help health officials establish a model that other pharmacies could follow, says Paul Weidle, the CDC epidemiologist in charge of the project.

Free HIV tests are widely available at local health departments and community organizations. Most people get tested at their doctor's office as part of routine health screens, paying a nominal fee for the test or the visit. Test samples are collected by oral swab or from a blood sample taken by a finger prick device.

Pharmacists or nurse practitioners at the pilot clinics use an oral swab of the gums or inside the cheek. The FDA-approved HIV tests produce results within 20 minutes. If the test comes out as a preliminary positive, the patient will be referred to a local health-care provider for confirmation and care.

The tests are conducted in private rooms. "This is a non-descript type of place. Nobody really knows what you're in there for," said Mike Ellis, Walgreen's vice president of specialty and infusion.

Walgreen has also trained its pharmacists in recent years to take tests for blood pressure, cholesterol and diabetes. The pharmacists who can provide counseling about HIV treatments or conduct a test receive about 25 hours of training every year, said Glen Pietrandoni, senior manager of HIV/AIDS and Hepatitis at Walgreen.

-For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

(END) Dow Jones Newswires

June 27, 2012 17:56 ET (21:56 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
21 mar
PNDORA
  Jeg har flere gange analyseret Pandora, senest efter årsregnskabet. Den seneste tid har kursen vær..
61
21 mar
E:QEC
At jeg gør som jeg gør, og et lille indblik i hvilke gabs vi har liggende som sagtens kan fyldes på ..
24
23 mar
I:DAX
@marc55.   Lad mig give dig et velment råd.   Jeg er ikke en gammel sur mand (hverken gammel eller s..
19
21 mar
FING-B
Baronen84, jeg tager hatten af for dine RTX aktier, det er flot set :-)   Men at være hånlig overfor..
18
24 mar
RTX
vi er  mange der er glade for at slippe for dig. TAK TIL EI.
17
22 mar
OMXC25
Det var så vigtigt vi skulle stemme. Jeg er glad for det blev et NEJ.   EU sagde vi ikke ville få en..
17
21 mar
VWS
idiot
15
23 mar
VWS
Dong Energy og Vestas får meldinger om off shore industrien, hvor de store olieselskaber øjnene muli..
14
24 mar
RTX
Skynd dig at få fyret de sidste 2 indlæg af.. så vi kan få fred resten af dagen.
13
22 mar
GEN
Genmab kommer minimum i kurs 2000 over tid - og hvad der sker i mellemtiden rager mig personligt en ..
13

Novo: EMA-udvalg anbefaler markedsføringstilladelse til Refixia - NY

24-03-2017 13:31:36
Udvalget for humanmedicinske lægemidler (CHMP) ved Det Europæiske Lægemiddelsagentur (EMA) har tildelt Novo Nordisks Refixia en positiv udtalelse og anbefaler en markedsføringstilladelse.Det skriver Novo Nordisk i en fondsbørsmeddelelse.CHMP anbefaler en markedsføringstilladelse til Refixia til unge og voksne med hæmofili B. Til grund for anbefalingen ligger resultater fra udviklingsprogrammet par..

Novo/Exane: Kursmålet skæres til 270 kr.

24-03-2017 10:17:22
Den franske storbank Exane BNP Paribas skærer kursmålet for aktien i Novo Nordisk til 270 kr. fra 295 kr. Anbefalingen er uændret "outperform", viser data fra Bloomberg.Novo-aktien falder fredag 0,4 pct., eller 1 kr., til 233,20 kr. Det dækker dog over en stigning, da aktien ikke længere handles inklusive retten til et udbytte på 4,60 kr./ritzau/FINANSJakob Dalskov +45 33 30 03 35 Ritzau Finans, E..

Aktier/tendens: Mulighed for mere gas til Mærsk i ventet rødt C20

24-03-2017 08:31:54
Det danske aktiemarked kan fredag blive præget af små udsving med en lille overvægt af negative fortegn.A.P. Møller-Mærsks B-aktie var uændret efter torsdagens handel og blev handlet til 11.500 kr. Aktien kan dog gå fra grå til grøn fredag, da der er potentielt gode nyheder til det danske konglomerat.Efter en Nordsø-aftale, der kan redde det ellers lukningstruede Tyra-felt, skriver Jyllands-Posten..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. marts 2017 04:48:38
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170324.2 - EUROWEB4 - 2017-03-27 04:48:38 - 2017-03-27 04:48:38 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x